Homozygosity for a gross partial gene deletion of the C-terminal end of ATP7B in a Wilson patient with hepatic and no neurological manifestations

被引:27
|
作者
Moller, LB
Ott, P
Lund, C
Horn, N
机构
[1] John F Kennedy Inst, DK-2600 Glostrup, Denmark
[2] Aarhus Univ Hosp, Dept Hepatogastroenterol 5, DK-8000 Aarhus, Denmark
关键词
Wilson disease; hepatic type; partial gene deletion; ATP7B; molecular diagnosis;
D O I
10.1002/ajmg.a.30977
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
We identified a partial gene deletion of ATP7B in a patient with Wilson disease with hepatic onset. The deletion covered exon 20 including major parts of the flanking introns. The breakpoints were identified and the size of the deletion determined to be 2144 bp. The deletion is predicted to lead to a mutated protein product containing 45 aberrant amino acids after transmembrane domain 7, and lacking the transmembrane domain 8 as well as the entire C-terminal cytoplasmic tail. This is the first time a partial gene deletion has been demonstrated in ATP7B. The patient presented at age 10 with hepatic manifestations, including severe jaundice, hepato-splenomegaly, ascites, and spider naevi. The liver biopsy showed fibrosis and early signs of cirrhosis. There was a Kayser-Fleischer ring but no neurological manifestations. All symptoms disappeared with penicillamine therapy. This suggests that the C-terminal cytoplasmatic tail of ATP7B, is not essential for its neurological function. Large deletions in ATP7B may be an overlooked cause of Wilson disease. Patients that are homozygotes for deletions may be valuable for the understanding of the function of various regions of the ATP7B protein. (c) 2005 Wiley-Liss, Inc.
引用
收藏
页码:340 / 343
页数:4
相关论文
共 25 条
  • [21] Generation of an integration-free induced pluripotent stem cell (iPSC) line (ZZUNEUi004-A) from a Wilson's disease patient harboring a homozygous Pro992Leu mutation in ATP7B gene
    Zhang, Jiwei
    Wei, Liting
    Chen, Dingbang
    Feng, Li
    Wu, Chao
    Wang, Rui
    Li, Xunhua
    Liu, Hongbo
    STEM CELL RESEARCH, 2020, 44
  • [22] Generation of an integration-free induced pluripotent stem cell (iPSC) line (ZZUNEUi005-A) from a Wilson's disease patient harboring a homozygous Pro992Leu mutation in ATP7B gene
    Wei, Liting
    Zhang, Jiwei
    Chen, Dingbang
    Feng, Li
    Wu, Chao
    Wang, Rui
    Li, Xunhua
    STEM CELL RESEARCH, 2020, 47
  • [23] Generation of an integration-free induced pluripotent stem cell (iPSC) line (ZZUNEUi003-A) from a Wilson's disease patient harboring a homozygous R778L mutation in ATP7B gene
    Zhang Jiwei
    Wei Liting
    Chen Dingbang
    Feng Li
    Wu Chao
    Wang Rui
    Li Xunhua
    STEM CELL RESEARCH, 2019, 41
  • [24] Generation of an induced pluripotent stem cell (iPSC) line (IGIBi026-A) derived from Wilson disease patient harboring compound heterozygous mutations [c.2165dupT (p.R723Efs31) and c.C813A (p.C271*)] in the ATP7B gene
    Saikia, Bhaskar Jyoti
    Bhardwaj, Juhi
    Saini, Arti
    Rajan, Roopa
    Binukumar, B. K.
    STEM CELL RESEARCH, 2024, 81
  • [25] Generation of an induced pluripotent stem cell line ICGi030-A from a Wilson's disease patient carrying a frameshift mutation p.Lys1013fs and missense mutation p.H1069Q in the ATP7B gene
    Zhigalina, D., I
    Malakhova, A. A.
    Vasilyeva, O. Yu
    Grigor'eva, E., V
    Sivtsev, A. A.
    Kolesnikov, N. A.
    Lopatkina, M. E.
    Savchenko, R. R.
    Zhalsanova, I. Zh
    Postrigan', A. E.
    Zarubin, A. A.
    Nikitina, T., V
    Bueverov, A. O.
    Bogomolov, P. O.
    Zakian, S. M.
    Skryabin, N. A.
    STEM CELL RESEARCH, 2021, 57